EBV Lymphomas
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Effectiveness of EBV-specific Cytotoxic T Cells for the Treatment for EBV Lymphomas or Other EBV-associated Malignancies (NCT03988582) | Memorial Sloan Kettering Cancer Center | 2019-06-11 |
| Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies (NCT00917826) | HemaQuest Pharmaceuticals Inc. | 2008-09-01 |
Track EBV Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.